Home › Funds › KLEIN PAVLIS & PEASLEY FINANCIAL, INC. › ABT

KLEIN PAVLIS & PEASLEY FINANCIAL, INC. position in ABT

ABBOTT LABORATORIES · Health Care

KLEIN PAVLIS & PEASLEY FINANCIAL, INC. reported holding 31,125 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 1.56% of its reported portfolio and ranking #19 among its reported holdings. KLEIN PAVLIS & PEASLEY FINANCIAL, INC. has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)31.12K sh
Reported value held$3.08M
Portfolio Weight1.56%
First reportedQ2 2025
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How KLEIN PAVLIS & PEASLEY FINANCIAL, INC.'s ABT position evolved

KLEIN PAVLIS & PEASLEY FINANCIAL, INC. first disclosed a stake in ABT in Q2 2025 at 17,000 shares (US$2.3M). The position peaked in Q3 2026 at 31,125 shares, worth US$3.1M. Across 6 filings, KLEIN PAVLIS & PEASLEY FINANCIAL, INC. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 31,125 shares valued at US$3.1M — an increase of 1,525 shares quarter over quarter.. Notable position changes include a 31% increase in Q3 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 17.00K $2.31M New
Q3 2025 22.30K $2.99M Add
Q4 2025 22.42K $2.81M Add
Q1 2026 25.84K $2.65M Add
Q2 2026 29.60K $2.69M Add
Q3 2026 31.12K $3.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has KLEIN PAVLIS & PEASLEY FINANCIAL, INC. held ABT?

KLEIN PAVLIS & PEASLEY FINANCIAL, INC. has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is KLEIN PAVLIS & PEASLEY FINANCIAL, INC.'s current position in ABT?

As of Q3 2026, KLEIN PAVLIS & PEASLEY FINANCIAL, INC. holds 31.12K shares of ABT (ABBOTT LABORATORIES), valued at $3.08M, representing 1.56% of its reported portfolio and ranking #19.

Has KLEIN PAVLIS & PEASLEY FINANCIAL, INC. been buying or selling ABT?

In the latest 13F filing (Q3 2026), KLEIN PAVLIS & PEASLEY FINANCIAL, INC. increased its position in ABT. The position peaked in Q3 2026 at 31.12K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.